Prostaglandin-Endoperoxide Synthase 2 (PTGS2) Expression Is Increased in Chronic Asymptomatic Orchitis in the Dog.
- 1Unit for Reproductive Medicine, Clinic for Small Animals, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, Germany.
Abstract
Chronic asymptomatic orchitis (CAO) in dogs lacks effective treatment options. To elucidate the involvement of prostaglandin endoperoxide synthase 2 (PTGS2), associated with inflammation and physiological steroidogenesis, testicular PTGS2 and StAR gene (via RT-qPCR) and protein expression (via immunohistochemistry) were analyzed in 11 canine CAO samples and compared to five normospermic control group (CG) samples. The percentage of immunopositive area (PIA) and mean gray scale (MGS) intensity were evaluated in the interstitial and tubular compartments. In CAO, PTGS2 and StAR gene expression levels were significantly increased compared to CG (p < 0.001 and p = 0.0034). Leydig cells and some peritubular cells stained immunopositive for PTGS2 and StAR and Sertoli cells positive for PTGS2. PIA and MGS for PTGS2 differed significantly between groups in the interstitial (PIA: p < 0.0001; MGS: p = 0.0051) and tubular (PIA: p = 0.0006; MGS: p = 0.0413) compartments. For StAR, PIA, but not MGS, was significantly higher in CAO (p = 0.0010). Except for PTGS2 gene expression, higher degrees of spermatogenetic impairment correlated with more prominent expression changes. This study demonstrates an association between increased PTGS2 expression and CAO. Further research is needed to investigate potential clinical benefits of selective PTGS2 inhibitors.
Related
- Increased expression of hPGDS‑PGD2 in patients with eosinophilic chronic rhinosinusitis with nasal polyps
- Colonic LRRK2 expression is increased in Crohn's disease but not in Parkinson's disease and idiopathic RBD
- Blood-Based vs. Tissue-Based mRNA Expression of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase, and Methylenetetrahydrofolate Reductase: A Prospective Study to Predict the Neoadjuvant CAPEOX Response in Advanced Colorectal Cancer
- TRMT112 Expression Is Associated With Poor Prognosis and Increased Invasive Potential in Oral Squamous Cell Carcinoma
- Gβγ dually regulates the M current via increased channel surface expression and PIP2 sensitivity
BibTeX
@article{packeiser2026prostaglandinendoperoxide,
title = {{Prostaglandin-Endoperoxide Synthase 2 (PTGS2) Expression Is Increased in Chronic Asymptomatic Orchitis in the Dog.}},
author = {Eva-Maria Packeiser and Hanna Körber and Judith Morawietz and Sandra Goericke-Pesch},
journal = {Veterinary sciences},
year = {2026},
month = oct,
doi = {10.3390/vetsci13101110},
url = {https://europepmc.org/article/MED/42944204},
note = {CC BY},
}
RIS
TY - JOUR
TI - Prostaglandin-Endoperoxide Synthase 2 (PTGS2) Expression Is Increased in Chronic Asymptomatic Orchitis in the Dog.
AU - Eva-Maria Packeiser
AU - Hanna Körber
AU - Judith Morawietz
AU - Sandra Goericke-Pesch
PY - 2026
DA - 2026/10/17
JO - Veterinary sciences
DO - 10.3390/vetsci13101110
UR - https://europepmc.org/article/MED/42944204
AB - Chronic asymptomatic orchitis (CAO) in dogs lacks effective treatment options. To elucidate the involvement of prostaglandin endoperoxide synthase 2 (PTGS2), associated with inflammation and physiological steroidogenesis, testicular PTGS2 and StAR gene (via RT-qPCR) and protein expression (via immunohistochemistry) were analyzed in 11 canine CAO samples and compared to five normospermic control group (CG) samples. The percentage of immunopositive area (PIA) and mean gray scale (MGS) intensity were evaluated in the interstitial and tubular compartments. In CAO, PTGS2 and StAR gene expression levels were significantly increased compared to CG (p < 0.001 and p = 0.0034). Leydig cells and some peritubular cells stained immunopositive for PTGS2 and StAR and Sertoli cells positive for PTGS2. PIA and MGS for PTGS2 differed significantly between groups in the interstitial (PIA: p < 0.0001; MGS: p = 0.0051) and tubular (PIA: p = 0.0006; MGS: p = 0.0413) compartments. For StAR, PIA, but not MGS, was significantly higher in CAO (p = 0.0010). Except for PTGS2 gene expression, higher degrees of spermatogenetic impairment correlated with more prominent expression changes. This study demonstrates an association between increased PTGS2 expression and CAO. Further research is needed to investigate potential clinical benefits of selective PTGS2 inhibitors.
SN - 2306-7381
ER -